Qyuns Therapeutics announces annual general meeting

• Qyuns Therapeutics will hold its annual general meeting in Taizhou City, Jiangsu Province on May 29, 2026.
• Shareholders will vote on 2025 reporting items, including board report, supervisors report, annual report with audited consolidated financial statements, profit distribution plan, director and supervisor remuneration plan, auditor appointment, and a proposed change in use of global offering proceeds.
• Special resolutions include proposed general mandates to issue shares and to repurchase H shares.
• Other items include dissolving supervisory committee with related governance document amendments, and adopting 2026 share incentive scheme with related mandate limits.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qyuns Therapeutics Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260508-12153798), on May 08, 2026, and is solely responsible for the information contained therein.